Skip to main content
. 2022 Oct 6;14(1):2128603. doi: 10.1080/19490976.2022.2128603

Figure 2.

Figure 2.

Resistome expansion persists for 6 months in antibiotic-naive COVID-19 patients. Dynamics of the observed ARG types (a), subtypes (b) and normalized abundance (c) in antibiotic-naive COVID-19 patients from baseline to 6-month follow-up. (d) Bray–Curtis dissimilarity of ARGs (‘types’) in stool samples from baseline to 6-month follow-up. (e) Abundance of antibiotic resistance ‘types’ in stool samples from baseline to 6-month follow-up. (f) The normalized abundance of ARGs in subjects with PACS is significantly higher than that of subjects without PACS at 6-month follow-up.